Buscar resultados de ensayos clínicos

Patrocinado por

AL Amyloidosis - 146 Studies Found

Estado Estudiar
Completed Nombre del estudio: Low-Dose Melphalan and Dexamethasone Compared With High-Dose Melphalan Followed By Autologous Stem Cell Transplant in Treating Patients With Primary Systemic Amyloidosis
Condición: Multiple Myeloma and Plasma Cell Neoplasm
Fecha: 2007-05-23
Intervenciones:
  • Biological: filgrastim No admi
Terminated Nombre del estudio: Amifostine and Melphalan in Treating Patients With Primary Systemic Amyloidosis Who Are Undergoing Peripheral Stem Cell Transplantation
Condición:
  • Drug/Agent Toxicity by Tissue/Organ
  • Multiple Myeloma and Plasma Cell Neoplasm

Fecha: 2003-01-24
Intervenciones:
  • Biological: filgrastim
  • Drug: amifostine tr
Active, not recruiting Nombre del estudio: A Trial for the Treatment of Cardiac AL-Amyloidosis With the Green Tea Compound Epigallocatechin-3-gallate (TAME-AL)
Condición:
  • Light Chain (AL) Amyloidosis
  • Cardiac Involvement

Fecha: 2013-11-18
Intervenciones:
  • Drug: Epigallocatechin-3-gallate (EGCG)

Active, not recruiting Nombre del estudio: Tandem Autologous Stem Cell Transplantation in Treating Patients With Primary Systemic (AL) Amyloidosis
Condición: Multiple Myeloma
Fecha: 2004-01-09
Intervenciones:
  • Drug: filgrastim 16 mg/kg/day

Terminated Nombre del estudio: 2nd Autologous Stem Cell Transplant in Patients With Persistent/Recurrent (AL) Amyloidosis
Condición:
  • Multiple Myeloma
  • Plasma Cell Neoplasm

Fecha: 2004-01-09
Intervenciones:
  • Biological: filgrastim 16mcg/k
Completed Nombre del estudio: Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients Who Have Multiple Myeloma or Primary Systemic Amyloidosis
Condición: Multiple Myeloma and Plasma Cell Neoplasm
Fecha: 2001-01-06
Intervenciones:
  • Biological: filgrastim
  • Biological: recombi
Withdrawn Nombre del estudio: Mixed Chimeric Transplantation for Primary Amyloidosis
Condición:
Fecha: 2025-09-05
Active, not recruiting Nombre del estudio: Bortezomib and Dexamethasone Followed by High-Dose Melphalan and Stem Cell Transplantation for Primary (AL) Amyloidosis
Condición: Amyloidosis
Fecha: 2009-11-02
Intervenciones:
  • Drug: Bortezomib

Completed Nombre del estudio: Autologous Stem Cell Rescue for Primary Amyloidosis
Condición:
  • Amyloidosis
  • Blood and Marrow Transplant (BMT)

Fecha: 2005-09-13
Intervenciones: Procedure: high dose chemo then auto hematopoietic cell transplant
Completed Nombre del estudio: Efficacy of CC-5013 (Revlimid or Lenalidomide) in Patients With Primary Systemic Amyloidosis
Condición: Amyloidosis
Fecha: 2005-09-12
Intervenciones: Drug: CC-5013 40 mg/day orally on days 1-4 and 15-18 of each 28-day cycle
<<< Previous | Next >>>